Differences in Rates of High-Value and Low-Value Care Between Community Health Centers and Private Practices

Abstract

Background

Community health centers (CHCs) are an integral part of the health care safety net. As health systems seek to improve value, it is important to understand the quality of care provided by CHCs.

Objective

To evaluate the performance of CHCs compared with private practices on a comprehensive set of high-value and low-value care measures.

Design

This cross-sectional study used data from the National Ambulatory Medical Care Survey from 2010 through 2012. We compared CHCs with private practices using logistic regression models that adjusted for age, sex, race/ethnicity, insurance, number of chronic illnesses, rural versus urban location, region of country, and survey year.

Setting/Participants

We included outpatient visits to generalist physicians at either CHCs or private practices by patients 18 years and older.

Main Measures

We examined 12 measures of high-value care and 7 measures of low-value care.

Results

A total of 29,155 physician visits, representing 584,208,173 weighted visits, from 2010 through 2012 were included. CHCs were more likely to provide high-value care by ordering beta-blockers in CHF (46.9% vs. 36.5%; aOR 2.56; 95%CI 1.18–5.56), statins in diabetes (37.0% vs 35.5%; aOR 1.35; 95%CI 1.02–1.79), and providing treatment for osteoporosis (35.7% vs 23.2%; aOR 1.77; 95%CI 1.05–3.00) compared with private practices. CHCs were more likely to avoid low-value screening EKGs (98.7% vs. 88.0%; aOR 11.03; 95%CI 2.67–45.52), CBCs (75.9% vs. 65.7%; aOR 1.72; 95%CI 1.18–2.53), or urinalyses (86.0% vs. 80.5%; aOR 1.87; 95%CI 1.11–3.14) during a general medical exam. CHCs were also less likely to prescribe antibiotics for a URI (48.3% vs. 63.1%; aOR 0.59; 95%CI 0.40–0.88).

Conclusions

On a number of high-value and low-value measures of care, CHCs performed similar to or better than private practices. As healthcare delivery reforms continue to progress, CHCs are well positioned to provide high-value healthcare.

BACKGROUND

Community health centers (CHC) are comprehensive primary care clinics located in underserved areas of the country and serve a unique mission to provide care for all patients regardless of income or insurance status. CHCs include both federally qualified health centers (FQHCs) and FQHC look-alike clinics which meet the structural and organizational requirements of FQHCs but do not receive the same federal grants. Since their establishment in the 1960s, CHCs have grown to include nearly 1,400 practices nationally that care for more than 27 million people.¹

CHCs are largely funded through a prospective payment system set by Medicaid in addition to federal grants that cover the costs of caring for the uninsured. The latter includes Section 330 grants of the Public Health Act, which confers the FQHC designation. In 2015, federal funding for CHCs totaled $21 billion, with 44% through Medicaid, 18% from Section 330 grants, and the remainder coming from Medicare, commercial insurers, self-pay, and various grants.² Given the significant federal funding allocated to CHCs, policymakers have long been interested in understanding the quality of care they provide.

Prior work has arrived at differing conclusions regarding the provision of high-value care and the avoidance of low-value care at CHCs compared with non-CHC practices. High-value care describes the delivery of guideline-concordant care that improves health, avoids harms, and eliminates wasteful practices.³ This includes preventative care, which has been shown to be delivered at higher rates at CHCs compared with that to non-CHCs.⁴ The only national study to examine high-value chronic disease measures demonstrated that CHCs had higher rates of adherence on process measures for coronary artery disease and congestive heart failure compared with private practices.⁵

Low-value care encompasses the overutilization of services that provide marginal or unknown benefit to patients. Such measures of low-value care, which include unnecessary testing and preventable utilization of hospital settings, have received greater attention due to efforts like the Choosing Wisely campaign from the American Board of Internal Medicine (ABIM).⁶ Prior studies that have examined rates of potentially preventable hospitalizations (also called ambulatory care-sensitive admissions) among patients at CHCs compared with those at non-CHCs were limited in size and scope, and have yielded divergent results.^7–9

Other recent works examining safety net providers, more broadly defined than CHCs, found they provided comparable rates of low-value care as non-safety net providers nationally.¹⁰ CHCs are unique within the safety net, however, due to the statutory requirements tied to their funding. Under the purview of Section 330 of the Public Health Act, CHCs are governed by a patient majority board and must provide services according to local needs.¹¹ These additional requirements and community responsibilities may influence how they spend their scarce resources. The rates of low-value care within CHCs in particular remain unclear.

As value-based health reform continues to grow in scope, our study builds on this prior work and aims to compare the performance of CHCs with that of private practices on a comprehensive set of high-value and low-value measures. We employ a national cross-sectional survey previously used to describe the delivery of health services in the USA.

METHODS

Data Source and Study Design

We used publicly available data from the National Ambulatory Medical Care Survey (NAMCS) from 2010 through 2012. NAMCS is a nationally representative survey of non-federal office-based clinicians that is conducted annually by the National Center for Health Statistics (NCHS). NAMCS uses a 3-stage probability sampling design based on geographic area (also called primary sampling units or PSUs), physician practices within PSUs, and patient visits within the practice. Within the practice, each physician is randomly assigned to a 1-week reporting period. During this period, US Census Bureau interviewers record a systematic random sample of visits. Visits are then weighted to national estimates of ambulatory care based on the inverse probability of selection at each stage of the sampling design. A comprehensive description of the methods used for data collection, sampling, and weighting in NAMCS is available at https://www.cdc.gov/nchs/ahcd/ahcd_questionnaires.htm.

Between 2006 to 2012, the NCHS collected an additional sample of visits to community health center sites. This included visits to FQHCs, FQHC look-alikes, and Urban Indian FQHCs.¹² We selected the years 2010–2012, which were the most recent years available at the time of analysis, to provide a baseline sample of visits coinciding with the start of the national Choosing Wisely campaign, as well as delivery system reforms under the Affordable Care Act (ACA). Response rates from CHCs ranged from 76.1% in 2011 to 81.3% in 2012. The NCHS evaluated for non-response bias at both physician and visit levels. Additional details regarding sampling techniques and response rate are available online.

Our analysis was conducted at the visit level and included all visits from patients 18 years of age and older to primary care physicians who met the inclusion criteria. The inclusion criteria included the receipt of high-value or low-value care as described below. Primary care physicians included general internists, general physicians, and family physicians. Non-physician clinicians, such as nurse practitioners and physician assistants, were not included since there were differences in how they were sampled prior to the 2012 survey year. We limited analyses to private practices and community health centers only.

Definitions

CHCs were defined as FQHCs receiving Section 330 funding, FQHC look-alikes, which applied for but did not receive Section 330 funding, and Urban Indian Health Service clinics. CHCs were identified using data from the Health Resources and Services Administration’s Bureau of Primary Health Care and the Indian Health Service.

Private practices were defined as clinics that were in the solo or group practice setting. Hospital-based outpatient clinics, which are only available through the National Hospital Ambulatory Care Survey, were not included.

Primary Outcomes

Consistent with prior studies and guidelines, our outcomes encompassed the delivery of high-value and low-value care for common conditions in the primary care setting. We examined twelve measures of high-value care, including prescriptions for (1) aspirin, (2) beta blockers, or (3) statins in coronary artery disease; prescriptions for (4) beta blockers and (5) angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARB) for congestive heart failure (CHF); (6) prescriptions for anticoagulants in atrial fibrillation; (7) prescriptions for antiplatelets in cerebrovascular disease; (8) prescriptions for statins in diabetes mellitus; (9) weight reduction counseling for patients with obesity; (10) tobacco cessation counseling; (11) treatment for depression; and (12) treatment for osteoporosis.^{5, 10, 13–16} The seven measures of low-value care include (1) antibiotic prescriptions for an upper respiratory infection (URI), (2) opioid prescriptions for headaches, (3) opioid prescriptions for back or neck pain, (4) ordering of a CT or MRI for back or neck pain, and avoidance of routine tests during a general medical exam in the absence of symptoms, including avoidance of (5) routine electrocardiography (ECG), (6) complete blood counts (CBC), and (7) urinalysis (UA).^{5, 10, 13, 14, 17–20}

Each measure was constructed as a weighted percentage stratified by CHC versus private practice, where receipt of the high-value or low-value service was counted in the numerator. All clinical encounters that were eligible for the receipt of a high-value or low-value service were included the denominator. In some cases, a clinical encounter could be counted under several measures. Prescriptions were identified using medication codes provided in NAMCS and the ordering of diagnostic tests was directly captured through distinct variables in the survey.

Inclusion and Exclusion Criteria

Inclusion criteria for eligible visits were derived from primary and secondary International Classification of Diseases, Ninth Revision (ICD-9) diagnostic codes, reason for visit codes, and the fourteen chronic illness comorbidities that are directly captured in the survey. This was based on prior literature and codes are included in the Appendix. Exclusions were based on the presence of clinical red flags (i.e., history of malignancy when MRI is ordered for back pain) or possible contraindications to receiving care (i.e., history of gastrointestinal bleeding when anticoagulant for atrial fibrillation is not prescribed). The percentage was calculated as a weighted percentage with 95% confidence intervals provided.

Statistical Analysis

We report clinical and demographic characteristics by site of care, comparing CHCs with private practices. To examine the association between site of care and performance on each high-value and low-value care measure, we constructed multivariable logistic regression models combining data across all 3 years. The models adjusted for age, sex, race/ethnicity, insurance, number of chronic illnesses, rural versus urban status based on metropolitan statistical area, region of country, and survey year. Race/ethnicity was collapsed into the categories of non-Hispanic white, non-Hispanic black, Hispanic/Latino, and other. Self-pay and no charge/charity were collapsed into uninsured, while dual-eligible patients were collapsed into the Medicaid category for insurance status. The total number of chronic illnesses is routinely measured in the survey and is extracted from the medical record and problem list.

We performed all analyses in SAS Version 9.2 using previously reported methods that account for the complex survey design, including disproportionate survey weights, the multistage sampling frame, and clustering within geographic units and physicians.²¹ Our analyses followed the NCHS requirements for deriving national estimates based on the absolute number of sampled visits and relative standard error.¹²

95% confidence intervals are reported and 2-sided p values < 0.05 were considered statistically significant.

Ethical Approval

The University of Rochester Research Subjects Review Board approved this study.

RESULTS

Between 2010 and 2012, a total of 29,155 unweighted visits, representing 584.2 million weighted visits nationally, met the inclusion criteria for at least one quality metric. A total of 37.6 million weighted visits were to community health centers and 546.6 million were to private practices. Patients seen at CHCs tended to be younger compared with those at private practices. CHCs were more likely to see patients who were African American, Hispanic/Latino, insured by Medicaid, and uninsured. Additionally, patients in rural areas and in the western geographic area of the USA were more likely to be seen at CHCs (Table 1).

Table 1.

Characteristics of Patient Visits to CHCs vs Private Practices, 2010–2012

Characteristics	CHC (n = 11,905)	Private practices (n = 17,250)	p Value
Weighted visits (million)	37.6	546.6
Age (mean)	50.7	56.4	< 0.001
Female sex (%)	59.8	56.7	0.04
Race/ethnicity (%)			< 0.001
Non-Hispanic White	47.0	74.0
Non-Hispanic African
American	20.1	12.6
Hispanic	28.4	9.4
Other	4.6	3.9
Insurance			< 0.001
Medicaid	31.7	10.0
Medicare	17.5	30.8
Private	15.5	49.0
Uninsured	19.6	4.9
Other	9.9	1.5
Unknown	5.9	3.8
Comorbidities			0.005
0	15.1	17.5
1–2	48.9	45.2
3–4	31.0	29.5
5+	5.0	7.8
MSA			0.210
Rural	23.4	17.2
Practice census region			< 0.001
Northeast	19.4	20.9
Midwest	15.5	23.8
South	30.7	37.0
West	34.5	18.3

We examined the performance of CHCs and private practices using both unadjusted and adjusted analyses. Within unadjusted analyses, performance on high-value measures was low across both CHCs and private practices, with neither performing higher than 70% on any measure. On one measure, CHCs had higher rates of treatment for osteoporosis (35.7% vs 23.2%, p < 0.01, Table 2). Within unadjusted analyses, CHC had higher rates of avoidance of low-value screening EKGs and CBCs (98.7% vs 88.0%, p < 0.001; 75.9% vs 65.7%, p < 0.01, Table 2). They also had lower rates of prescribing of antibiotics in low-risk upper respiratory tract infections (48.3% vs 63.1%, p < 0.001, Table 2).

Table 2.

Unadjusted Rates of Performance Measures by Site of Care

Performance measures (%)	CHCs	Private practices	p Value
High-value care
Tobacco cessation counseling	57.6 (46.7, 68.6)	61.8 (52.7, 70.9)	0.55
Weight reduction counseling	34.0 (28.3, 39.8)	30.0 (26.7, 33.4)	0.24
Anticoagulant use in AFib	68.7 (55.7, 81.8)	59.3 (51.7, 66.9)	0.25
Aspirin use in CAD	43.5 (31.9, 55.1)	40.3 (34.6, 45.9)	0.64
BB use in CAD	47.5 (37.7, 57.3)	38.9 (32.6, 45.3)	0.14
Statin use in CAD	46.9 (37.3, 56.5)	44.9 (39.4, 50.5)	0.75
BB in CHF	46.9 (31.9, 61.9)	36.5 (30.6, 42.4)	0.20
ACEi/ARB in CHF	44.1 (28.8, 59.3)	31.6 (25.8, 37.4)	0.13
Antiplatelet use in CVD	31.8 (17.6, 46.0)	35.2 (28.9, 41.5)	0.70
Statin use in DM	37.0 (31.9, 42.1)	35.5 (32.6, 38.4)	0.62
Treatment for depression	50.6 (46.1, 55.0)	51.9 (49.5, 54.4)	0.58
Treatment for osteoporosis	35.7 (27.0, 44.4)	23.2 (18.8, 27.5)	0.007
Low-value care
No screening EKG in GME	98.7 (97.4, 99.9)	88.0 (84.2, 91.8)	< 0.001
No screening CBC in GME	75.9 (70.7, 81.0)	65.7 (61.9, 69.6)	0.003
No screening UA in GME	86.0 (81.5, 90.6)	80.5 (76.7, 84.2)	0.07
Antibiotics for URI	48.3 (40.9, 55.6)	63.1 (58.2, 68.0)	< 0.001
Opioids for back/neck pain	38.8 (33.7, 43.9)	36.4 (32.2, 40.7)	0.48
CT/MRI for back/neck pain	4.9 (3.1, 6.7)	5.2 (4.2, 7.0)	0.53
Opioids for headache	17.3 (10.7, 23.9)	13.2 (9.9, 16.5)	0.26

After adjustment for age, sex, race/ethnicity, insurance, number of chronic illnesses, rural versus urban status, region of country, and survey year, our multivariable models revealed that CHCs performed better than private practices on additional measures with respect to high-value and low-value care. Figure 1 depicts the provision of high-value care. CHCs were more likely to prescribe beta-blockers at visits for CHF (aOR 2.56; 95% CI 1.18, 5.56), prescribe statins in DM (aOR 1.35; 95% CI 1.02, 1.79) and provide treatment for osteoporosis (aOR 1.77; 95% CI 1.05, 3.00) compared with private practices. Figure 2 demonstrates the provision of low-value care by CHCs and private practices. CHCs were more likely to avoid screening UAs in general medical exams (aOR 1.87, 95% CI 1.11–3.14), screening EKGs (aOR 11.03; 95% CI 2.67, 45.52), and CBCs (aOR 1.72; 95% CI 1.18, 2.53). CHCs were also less likely to prescribe antibiotics for URIs (aOR 0.59; 95% CI 0.40, 0.88; Fig. 2).

Fig. 1.

Adjusted odds ratios of high-value care measures by site of care. OR is adjusted odds ratio for receipt of high-value care with private practices as the reference group. GME is general medical exam; BB is beta-blocker; ACEi is angiotensin-converting enzyme inhibitor; ARB is angiotensin receptor blockers.

Fig. 2.

Adjusted odds ratios of low-value care measures by site of care. OR is adjusted odds ratio for receipt of low-value care with private practices as the reference group. GME is general medical exam; OR for screening EKG in GME is truncated for visual ease.

DISCUSSION

In this national study, community health centers were associated with the delivery of more high-value services and fewer low-value services compared with private practices. Low-value care includes medical services for which the potential for harm exceeds the potential benefits or the benefits are unclear. Optimizing high-value services while limiting the provision of low-value care offers the potential to improve quality while at the same time reducing costs, which is the focus of the national ABIM Choosing Wisely campaign.⁶

We found that CHCs were more likely to deliver high-value care compared with private practices in three clinical conditions. CHCs were more likely to prescribe beta-blockers in CHF, statins in diabetes, and pharmacologic treatment for osteoporosis. While they were also more likely to deliver high-value care compared with private practices on nearly all other measures, these results were not statistically significant. The greater provision of high-value care may be related to multiple factors, including the organizational and policy advantages that CHCs have as a result of their unique position in the safety net. CHCs have access to collaborative learning partnerships and frequently engage in sustained quality improvement initiatives.²² In fact, a prior study examining a national program to improve cardiovascular preventative care found that CHCs had considerably higher rates of participation in quality improvement initiatives compared with physician-owned practices.²³ Similarly, some evidence suggests that CHCs may be more likely to escalate care for chronic conditions, like uncontrolled hypertension, compared with private practices.²⁴

During the same time period as our study, there was a concerted national effort to reform healthcare delivery and certify FQHCs as patient-centered medical homes (PCMH). PCMH adoption was, in turn, associated with improvements in FQHC quality.^25–27 Implementation of a PCMH model involves investing in care coordination, new health information technology, and redesign of care processes with tracking of patient outcomes and quality. While not directly examined in our study, this broader adoption of the PCMH model among CHCs (41% adoption in CHCs compared with 18% nationally) may explain the greater provision of high-value care at CHCs.^{27, 28}

In addition to providing more high-value services, we found that CHCs were more likely to avoid low-value care, such as unnecessary antibiotic prescriptions for URIs and unnecessary screening tests, such as EKGs, UAs, and CBCs during a general exam, compared with private practices. CHCs performed similarly on other low-value measures including the use of opioids and advanced imaging for back and neck pain. Our results are consistent with prior work that demonstrated that CHCs were more likely to avoid screening EKGs.⁵ We expand on the findings of this prior study, using recently characterized measures of low-value care to measure excess ordering of antibiotics, opioids, and advanced imaging.

Our findings differ slightly from a recent study that examined low-value care among broader safety net practices. In that analysis, safety net physicians were defined as those with a patient panel composed of at least 25% Medicaid or uninsured patients. Compared with non-safety net physicians, there were no significant differences in the delivery of low-value screening tests, antibiotics for URI, opioids for back and neck pain, CT scan for sinusitis, or advanced imaging for headache.¹⁰ Safety net providers did have lower use of advanced imaging for back or neck pain.¹⁰ An important difference between our findings and the previous study that may explain our discordant results is the inclusion of hospital-based outpatient clinics. While safety net practices had a similar payer mix as our sample of CHCs, approximately 20% of safety net providers were hospital-based outpatient clinics, which may be associated with higher rates of low-value care.²⁹ The ability of CHCs to limit low-value care may be related to the structural and organizational advantages previously described. Within encounters, physicians practicing at CHCs may be more likely to have conversations with their patients regarding the cost of care.³⁰ As a result, clinicians at CHCs may be more sensitive to their patients’ out-of-pocket costs and refrain from ordering unnecessary tests or prescribing unnecessary medications.

The broader implications of our work underscore the importance of CHCs for delivery system reform in general, and for care of underserved patient populations in particular. National healthcare reforms have begun to shift delivery systems away from fee-for-service payments toward value-based and alternative payment models. Similarly, many states have opted to participate in Medicaid waivers known as Delivery System Reform Incentive Programs. These waivers have been used to implement Medicaid accountable care organizations with varying degrees of financial risk, including fully capitated models.³¹ While there has been some concern that alternative payment models and value-based contracts may inadvertently exacerbate disparities by exposing CHCs to the risk of lower revenue, others have argued that such payment reform may lead to higher quality care and better outcomes.³² Our findings suggest that CHCs are positioned to perform well on the measures of high- and low-value care as payment reform expands among safety net health systems. However, caution must be exercised before drawing parallels to other clinical quality measures that might be more susceptible to patients’ social determinants of health, such as ambulatory care-sensitive admissions and all-cause 30-day readmissions.³³ Further work will be needed to elucidate the specific processes and best practices used by CHCs that may be applicable to other health systems as they seek to maximize value.

There are a number of limitations to our work. First, the use of survey data is susceptible to issues with sampling error; however, we used standardized methods employed in prior studies using NAMCS in addition to using multiple years of data. Second, the measures in our study may have misattributed patients based on exclusion and inclusion criteria, but we constructed these measures based on professional society recommendations and prior literature regarding high- and low-value care. Additionally, our measurement is limited by what codes are documented on an individual visit. Last, while we controlled for multiple factors, there is the possibility that residual confounding may exist. Within the multivariable regression models, we adjusted for patient insurance, but future work should examine how differences in managed care penetration in Medicaid and high-deductible health plans among the commercially insured may explain the differences observed between CHCs and private practices. Furthermore, our cross-sectional analysis is unable to establish causality. Additional studies are needed to understand the operational best practices that may explain our findings and are generalizable to the larger environment of outpatient settings.

CONCLUSION

Maximizing quality and limiting services that provide marginal or unknown benefit to patients are increasingly recognized as key components of healthcare reform. Using nationally representative data, our work shows that CHCs exceeded the performance of private practices on several high-value and low-value care measures and were comparable on all others. As healthcare reforms and alternative payment models continue to expand across safety net practices, CHCs are well positioned to perform well on the measures of both high- and low-value care.

Compliance with Ethical Standards

Disclaimer

The contents do not represent the views of the U.S. Department of Veterans Affairs or the US Government.

Ethical Approval

The University of Rochester Research Subjects Review Board approved this study.

Conflict of Interest

The authors declare that they do not have a conflict of interest.